Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Assosciated Steatotic Liver Disease Patients

NCT06759363 is registered in ClinicalTrials.gov with University Medical Center Zvezdara as lead sponsor.

NCT NCT06759363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Assosciated Steatotic Liver Disease Patients
Lead sponsor
University Medical Center Zvezdara
Phase
Phase 3
Overall status
Unknown status
Start date
January 4, 2024
Completion date
January 20, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

masld - metabolic dysfunction-associated steatotic liver disease